Department of Biochemistry, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
J Surg Res. 2010 Dec;164(2):266-75. doi: 10.1016/j.jss.2009.04.013. Epub 2009 May 15.
The exact pathogenesis of hepatic dysfunction in hyperthyroidism is still unknown. We aimed to investigate the pathogenesis of liver dysfunction caused by hyperthyroidism through inducing heme oxygenase-1 (HO-1) expression, which has antioxidant and anti-apoptotic properties.
Rats were divided into six groups: untreated (group 1), treated with zinc protoporphyrin (ZnPP) (group 2), treated with hemin (group 3), treated with tri-iodothyronine (T3) (group 4), treated with T3 and ZnPP (group 5), and treated with T3 and hemin (group 6). After 22 d, oxidative stress and antioxidant enzymes and the expression of HO-1, mitochondrial permeability transition, cytochrome c, Bax, Bcl-2, caspase-3, caspase-8, and caspase-3 activity, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay were examined.
Hyperthyroidism induced oxidative stress of liver tissue was ameliorated by HO-1 induction. Administration of hemin (HO-1 inducer) increased Bcl-2 expression. Decreased expression of cytochrome c was accompanied by a decrease in caspase-3, caspase-8, Bax expression, and caspase-3 activity. The apoptotic activity and oxidative damage were found to be increased by the administration of ZnPP (HO-1 inhibitor). Immunohistochemistry findings supported these results.
HO-1 induction plays a protective role in the pathogenesis of the liver dysfunction in hyperthyroidism. This effect is dependent on modulation of the antiapoptotic and antioxidative pathways by HO-1 expression.
甲状腺功能亢进症导致肝功能障碍的确切发病机制尚不清楚。我们旨在通过诱导具有抗氧化和抗凋亡特性的血红素加氧酶-1(HO-1)表达来研究由甲状腺功能亢进引起的肝功能障碍的发病机制。
大鼠分为六组:未处理组(第 1 组)、锌原卟啉(ZnPP)处理组(第 2 组)、血红素处理组(第 3 组)、三碘甲状腺原氨酸(T3)处理组(第 4 组)、T3 和 ZnPP 处理组(第 5 组)和 T3 和血红素处理组(第 6 组)。22d 后,检测氧化应激和抗氧化酶以及 HO-1、线粒体通透性转换、细胞色素 c、Bax、Bcl-2、caspase-3、caspase-8 和 caspase-3 活性的表达,以及末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)检测。
HO-1 诱导减轻了甲状腺功能亢进引起的肝组织氧化应激。血红素(HO-1 诱导剂)的给药增加了 Bcl-2 的表达。细胞色素 c 表达减少伴随着 caspase-3、caspase-8、Bax 表达和 caspase-3 活性降低。HO-1 抑制剂 ZnPP 的给药增加了细胞凋亡活性和氧化损伤。免疫组织化学结果支持这些结果。
HO-1 诱导在甲状腺功能亢进症导致的肝功能障碍发病机制中发挥保护作用。这种作用依赖于 HO-1 表达对细胞凋亡和抗氧化途径的调节。